The global hemodialysis and peritoneal dialysis market is estimated to garner a moderate revenue by the end of 2031 by growing at a CAGR of ~7% over the forecast period, i.e., 2022 – 2031. Further, the market generated a modest revenue in the year 2021. The growth of the market can primarily be attributed to the rising prevalence of chronic kidney disease (CKD)globally. For instance, in the year 2019, the prevalence of CKD was estimated to be ~13%, whereas patients with end-stage kidney disease (ESKD) in need of renal replacement therapy were estimated to be between ~4.9 and ~7 millionworldwide.
The increasing number of people with kidney failure today, can live because of treatments such as dialysis and kidney transplant. When kidneys can no longer clean the blood, dialysis is a way of doing this job. Hemodialysis and peritoneal dialysis help to removes body's wastes, extra salt and water, and helps to control blood pressure of any one suffering from chronic kidney diseases (CKD) or kidney infections. With the rising number of people suffering from various kidney disorders as well as CKD the need for hemodialysis and peritoneal dialysisis showing an upward trend, which in turn, is expected to create massive revenue generation opportunities for the key players operating in the global robotic angiography systems market during the forecast period. For instance, as per the data revealed by The International Society of Nephrology, ~850 million individuals suffered from some form of kidney diseases in 2020, globally, which is increasing every year.
Growing Geriatric Population–the elderly population is one of the most vulnerable patient groups for whom hemodialysis and peritoneal dialysis would be required. According to the United Nations Department of Economic and Social Affair’s, the World Population Ageing 2020 report, in the year 2020, people aged 65 years or above were estimated to be 727 million worldwide.
The hemodialysis and peritoneal dialysis market is segmented and analyzed for demand and supply by end-user into hospitals, dialysis centers and home care settings. Amongst these segments, the hospitals segment is anticipated to garner the largest revenue by the end of 2031, backed by the growing number of patient suffering from kidney transplant along with the surge in the number of patients on dialysis worldwide. For instance, in the year 2018, more than 785,000 Americansneeded dialysis or kidney transplant out of which ~554,000 patients received dialysis to replace kidney function and ~229,000had a kidney transplant done.
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Regionally, the global hemodialysis and peritoneal dialysis market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these, the market in North America is projected to hold the largest market share by the end of 2031, backed by the growing number of hospitals and overall expenditure on healthcare in the region.According to the Centers for Medicare & Medicaid Services, in the year 2020, the National Health Expenditure (NHE), grew by ~9.7% to ~USD 4.1 trillion which accounted for 19.7% of Gross Domestic Product (GDP) in United States.
The global hemodialysis and peritoneal dialysis market is further classified on the basis of region as follows:
Our in-depth analysis of the global hemodialysis and peritoneal dialysis market includes the following segments:
Top Featured Companies Dominating the Global Hemodialysis and Peritoneal Dialysis Market
FREQUENTLY ASKED QUESTIONS
Rising number of people suffering from CKD and upsurge in the number patients on dialysis are some of the major factors anticipated to drive the growth of the market.
The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2022 – 2031.
Stringent regulatory policies required for the manufacturing of dialysis products and possibilities of exposure to infectionsare some of the factors estimated to hamper the market growth.
The market in North America is projected to hold the largest market share by the end of 2031 and provide more business opportunities in the future.
The major players in the market are Baxter Healthcare Corporation, Medtronic, Asahi Kasei Medical Co., Ltd., DaVita Inc., Becton, Dickinson and Company (BD), Nipro Medical Corporation, Nikkiso Co., Ltd., and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by products, types, end-user and by region.
The hospital segment is anticipated to garner the largest market size by the end of 2031 and display significant growth opportunities.
Select License Type
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization